These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15316296)

  • 1. [Incidence of extended spectrum beta-lactamase (ESBL)-producing Enterobacteria in the area of Caltagirone (Sicily)].
    Bellissima P; Amato R
    Infez Med; 2004 Jun; 12(2):108-12. PubMed ID: 15316296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
    Giraud-Morin C; Fosse T
    Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of ESBL-positive Enterobacteriaceae in Mantova hospital (Italy)].
    Gattuso G; Tomasoni D; Palvarini L; Chiarelli C; Nespeca M; Stradoni R; Ceruti R; Ferri F; Scalzini A
    Infez Med; 2009 Sep; 17(3):164-8. PubMed ID: 19838088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enterobacteria producers of extended-spectrum beta-lactamase in a hospital from Venezuela].
    Tedesco Maiullari RM; Guevara A
    Infez Med; 2012 Jun; 20(2):93-9. PubMed ID: 22767307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
    Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-Spectrum Beta-Lactamase-Producing Bacteria in a Urology Ward: Epidemiology, Risk Factors and Antimicrobial Susceptibility Patterns.
    Medina-Polo J; Arrébola-Pajares A; Pérez-Cadavid S; Benítez-Sala R; Sopeña-Sutil R; Lara-Isla A; Alsonso-Isa M; Gil-Moradillo J; Justo-Quintas J; Miranda-Utrera N; Aguilar-Gisbert L; Passas-Martínez JB; Tejido-Sánchez Á
    Urol Int; 2015; 95(3):288-92. PubMed ID: 26394031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast].
    Guessennd N; Bremont S; Gbonon V; Kacou-Ndouba A; Ekaza E; Lambert T; Dosso M; Courvalin P
    Pathol Biol (Paris); 2008; 56(7-8):439-46. PubMed ID: 18926644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [THE APPLICATION OF SELECTIVE CHROMOGENIC AGAR FOR DETECTING ENTEROBACTERIA WITH PRODUCTION OF BETA-LACTAMASES].
    Korobova AG; Frolova LN; Kliasova GA
    Klin Lab Diagn; 2015 Nov; 60(11):53-7. PubMed ID: 26999867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
    Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
    PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital.
    Gibold L; Robin F; Tan RN; Delmas J; Bonnet R
    Clin Microbiol Infect; 2014 Jan; 20(1):O20-6. PubMed ID: 23927626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
    Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Bert F; Larroque B; Dondero F; Durand F; Paugam-Burtz C; Belghiti J; Moreau R; Nicolas-Chanoine MH
    Transpl Infect Dis; 2014 Feb; 16(1):84-9. PubMed ID: 24330161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
    Pilmis B; Delory T; Groh M; Weiss E; Emirian A; Lecuyer H; Lesprit P; Zahar JR
    Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013.
    Arnaud I; Maugat S; Jarlier V; Astagneau P;
    Euro Surveill; 2015; 20(36):. PubMed ID: 26536042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.